10/5/2012 12:28:44 PM - It was dropped from the Featured Stocks list on 10/03/12 based on the recent M&A news. Holding its ground since gapping up for a considerable gain and new all-time high on 9/28/12 following news it will be acquired by Medtronic Inc (MDT). See the Company Profile page and latest analysis under the headline, "Extended From Buyable Range Following Merger & Acquisition News ", for more details and a new annotated graph.

10/4/2012 12:13:30 PM - It was dropped from the Featured Stocks list on 10/03/12 based on the recent M&A news. Holding its ground since gapping up for a considerable gain and new all-time high on 9/28/12 following news it will be acquired by Medtronic Inc (MDT). See the Company Profile page and latest analysis under the headline, "Extended From Buyable Range Following Merger & Acquisition News ", for more details and a new annotated graph.

10/3/2012 6:21:00 PM - It will be dropped from the Featured Stocks list tonight based on the recent M&A news. Holding its ground since gapping up for a considerable gain and new all-time high on 9/28/12 following news it will be acquired by Medtronic Inc (MDT). See the latest FSU analysis for more details and a new annotated graph.

10/3/2012 12:37:19 PM - G - Holding its ground since gapping up for a considerable gain and new all-time high on 9/28/12 following news it will be acquired by Medtronic Inc (MDT). See the latest FSU analysis for more details and a new annotated graph.

10/2/2012 12:13:09 PM - G - Holding its ground today. Gapped up for a considerable gain and new all-time high on 9/28/12 following news it will be acquired by Medtronic Inc (MDT). See the latest FSU analysis for more details and a new annotated graph.

10/1/2012 12:35:33 PM - G - Holding its ground today. Gapped up for a considerable gain and new all-time high on 9/28/12 following news it will be acquired by Medtronic Inc (MDT).

9/28/2012 12:20:20 PM - G - Gapped up today for a considerable gain and new all-time high on news it will be acquired by Medtronic Inc (MDT).

9/26/2012 3:47:41 PM - G - Enduring distributional pressure this week. Consolidating above prior highs defining chart support above its 50 DMA line.

9/24/2012 12:23:07 PM - G - Enduring distributional pressure while consolidating above prior highs defining chart support above its 50 DMA line. It is extended from its prior base.

9/17/2012 3:56:18 PM - G - Consolidating in a healthy fashion above prior highs defining chart support above its 50 DMA line. It is extended from its prior base.

9/11/2012 1:44:53 PM - G - Above average volume is behind its 5th consecutive loss since a "negative reversal" on 9/05/12 at its all-time high. Prior highs in the $23 area define support to watch on pullbacks.

9/10/2012 3:30:49 PM - G - Down today with higher volume behind its 4th consecutive loss since a "negative reversal" on 9/05/12 at its all-time high. Prior highs in the $23 area define support to watch on pullbacks.

9/5/2012 12:22:44 PM - G - Reversed into the red after early gains today into new all-time high territory. It is extended from its latest base, meanwhile its prior highs in the $23 area define support to watch on pullbacks.

9/4/2012 12:19:24 PM - G - Color code is changed to green after getting extended from its latest base. Prior highs in the $23 area define support to watch on pullbacks. See the latest FSU analysis for more details and a new annotated graph.

8/30/2012 5:27:12 PM - Y - Finished near the session high today with a small loss. It was highlighted in yellow with pivot point cited based on its 8/16/12 high plus 10 cents in the earlier mid-day report while noted - "This Chinese Medical - Products firm is pulling back today following a gain with more than 3 times average volume on the prior session which technically helped it break out of an orderly flat base above its 50 DMA line. Prior highs in the $25-26 area were a stubborn resistance area, however overhead supply is not a great concern. Its small supply (S criteria) of only 22.8 million outstanding shares and low daily average volume can contribute to greater volatility in the event of institutional buying or selling so proper discipline is especially important. Reported earnings +41% on +26% sales revenues for the quarter ended June 30, 2012 versus the year ago period. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons." See the latest FSU analysis for more details and a new annotated graph.

8/30/2012 12:31:45 PM - Y - Color code is changed to yellow with pivot point cited based on its 8/16/12 high plus 10 cents. This Chinese Medical - Products firm is pulling back today following a gain with more than 3 times average volume on the prior session which technically helped it break out of an orderly flat base above its 50 DMA line. Prior highs in the $25-26 area were a stubborn resistance area, however overhead supply is not a great concern. Its small supply (S criteria) of only 22.8 million outstanding shares and low daily average volume can contribute to greater volatility in the event of institutional buying or selling so proper discipline is especially important. Reported earnings +41% on +26% sales revenues for the quarter ended June 30, 2012 versus the year ago period. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons.

8/24/2012 12:09:19 PM - Consolidating in a tight trading range for the past 5 weeks, finding support above its 50 DMA line. Reported earnings +41% on +26% sales revenues for the quarter ended June 30, 2012 versus the year ago period. Prior mid-day report repeatedly noted - "It faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons."

7/24/2012 12:05:04 PM - Pulling back today for a 3rd consecutive small loss. Paused after an impressive streak of 14 consecutive gains above prior highs. Prior mid-day report repeatedly noted - "It faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons."

7/23/2012 12:37:47 PM - The 7/20/12 mid-day report noted - "Paused today after an impressive streak of 14 consecutive gains above prior highs. It faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons."

7/20/2012 12:59:15 PM - Paused today after an impressive streak of 14 consecutive gains above prior highs. Prior mid-day reports noted - "It faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons."

7/19/2012 11:46:20 AM - Rallying above prior highs with an impressive streak of 14 consecutive gains. Prior mid-day reports noted - "It faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons."

7/18/2012 12:39:15 PM - Rallying above prior highs with an impressive streak of 13 consecutive gains. Prior mid-day reports noted - "It faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons."

7/17/2012 12:14:56 PM - Rallying above prior highs with an impressive streak of 12 consecutive gains, yet it faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons.

7/16/2012 12:08:21 PM - Rallying above prior highs with a streak of 11 consecutive gains, yet it faces some additional resistance due to overhead supply up through the $26 area. The Dec '11 and Mar '12 quarters showed strong sales revenues and earnings increases, improving following a streak of 3 sub par quarterly comparisons.